TA
REGN icon

Tiedemann Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Tiedemann Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$313K Hold
380
– – 0.01% 213
2023
Q2 		$273K Sell
380
-4
-1% -$3.08K 0.01% 211
2023
Q1 		$316K Sell
384
-5
-1% -$3.77K 0.01% 199
2022
Q4 		$281K Buy
389
+9
+2% +$6.64K 0.01% 201
2022
Q3 		$262K Hold
380
– – 0.02% 192
2022
Q2 		$225K Sell
380
-8
-2% -$5.2K 0.02% 204
2022
Q1 		$271K Buy
388
+8
+2% +$5.06K 0.01% 239
2021
Q4 		$240K Hold
380
– – 0.01% 255
2021
Q3 		$230K Sell
380
-20
-5% -$12.4K 0.01% 270
2021
Q2 		$224K Sell
400
-27
-6% -$13.7K 0.01% 334
2021
Q1 		$201K Buy
427
+13
+3% +$6.33K 0.01% 318
2020
Q4 		$200K Sell
414
-394
-49% -$213K 0.01% 306
2020
Q3 		$453K Sell
808
-34
-4% -$20.6K 0.02% 231
2020
Q2 		$524K Sell
842
-56
-6% -$31.8K 0.03% 210
2020
Q1 		$438K Buy
898
+103
+13% +$42.5K 0.03% 212
2019
Q4 		$299K Sell
795
-22
-3% -$7.4K 0.01% 245
2019
Q3 		$226K Buy
817
+122
+18% +$36.1K 0.01% 283
2019
Q2 		$218K Sell
695
-476
-41% -$158K 0.01% 274
2019
Q1 		$480K Buy
1,171
+135
+13% +$55.6K 0.02% 305
2018
Q4 		$387K Buy
1,036
+323
+45% +$118K 0.02% 323
2018
Q3 		$288K Buy
713
+18
+3% +$6.85K 0.02% 262
2018
Q2 		$240K Buy
+695
New +$217K 0.02% 268

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tiedemann Advisors's REGN Position: Q3 2023 in Review

Tiedemann Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2023 at 380 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #213.

Tiedemann Advisors first reported a position in REGN in Q2 2018 and has held it in 22 quarters since. The position peaked at $524K in Q2 2020. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Tiedemann Advisors held 380 shares of Regeneron Pharmaceuticals worth $313K as of Q3 2023.
  • Tiedemann Advisors left its Regeneron Pharmaceuticals share count unchanged in Q3 2023.
  • Regeneron Pharmaceuticals made up 0.01% of Tiedemann Advisors's portfolio in Q3 2023, its #213 holding.
  • Tiedemann Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
  • Tiedemann Advisors's Regeneron Pharmaceuticals position peaked at $524K in Q2 2020.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.